je.st
news
Tag: infectious
Merck Announces Publication of Pivotal Data from Phase 3 Clinical Studies of ZERBAXA (Ceftolozane/Tazobactam) in The Lancet and Clinical Infectious Diseases
2015-04-28 00:30:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that The Lancet and Clinical Infectious Diseases have published online the results from the pivotal Phase 3 clinical studies of ZERBAXA (ceftolozane/tazobactam) for Injection (1 g/0.5 g) in complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI), respectively. The results will also appear in forthcoming print issues of the journals. Language: English Contact: MerckMedia Contacts:Pam Eisele, 267-305-3558Robert Consalvo, 908-295-0928orInvestor Contacts:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: the
data
publication
studies
Merck Reaffirms Continued Commitment to Developing Innovative Medicines for the Treatment of Infectious Diseases at 25th Annual ECCMID Congress
2015-04-21 14:30:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today reaffirmed its longstanding commitment to discovering and developing novel medicines in the global fight against infectious diseases, including infections caused by resistant bacteria and other pathogens. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orRobert Consalvo, 908-295-0928orInvestors:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: treatment
continued
annual
developing
Climate Change Leads Rapid Emergence of Infectious Diseases
2015-02-18 15:33:00| Climate Ark Climate Change & Global Warming Newsfeed
EcoWatch: Climate change is creating conditions that are likely to increase the rate of infectious disease worldwide. Thats the key findings of two new studies that show viruses such as Ebola, H1N1 and TB, as well as dengue and yellow fevers could spread further and become more frequent because of our changing climate. In one recently published article, zoologists studied climate in two vastly different regionsthe tropics and the Arcticto gain an understanding of how climate change may affect the...
Tags: change
leads
rapid
diseases
Climate Change Poised Make Infectious Disease Outbreaks More Frequent
2015-02-16 20:53:00| Climate Ark Climate Change & Global Warming Newsfeed
Newsweek: As the catastrophic Ebola outbreak showed the world recently, the modern age of global air travel has made it far easier for disease to spread. But climate change, which is shuffling habitable zones for pathogen-carrying animals, is poised to make future outbreaks of infectious diseases such as Ebola, H1N1 and TB worse, and more frequent. In an article published Sunday in the journal Philosophical Transactions of the Royal Society B, two zoologists studying parasites in drastically different environments--one...
Tags: make
change
disease
frequent
Climate change leading to emergence of infectious disease
2015-02-16 18:18:00| Climate Ark Climate Change & Global Warming Newsfeed
Blue and Green: Climate change is causing the appearance of infectious diseases in new places and new hosts, according to a study. Researchers warn that climate change shifts habitats and could lead much more illness emerging in the future. Zoologist Daniel Brooks, who is affiliated with the University of Nebraska-Lincoln, conducted the study, which has been published in the Philosophical Transactions of the Royal Society B. The research argues that as habitats shift as a result of climate change, wildlife, crops,...
Tags: change
leading
disease
climate